Kavakcioglu Yardimci, B. Et Al. 2021. Apatinib sensitizes human breast cancer cells against navitoclax and venetoclax despite up-regulated bcl-2 and mcl-1 gene expressions. Turk Onkoloji Dergisi , vol.36, no.1 , 8-16.

Kavakcioglu Yardimci, B., Ozgun Acar, O., SEMİZ, A., & ŞEN, A., (2021). Apatinib sensitizes human breast cancer cells against navitoclax and venetoclax despite up-regulated bcl-2 and mcl-1 gene expressions. Turk Onkoloji Dergisi , vol.36, no.1, 8-16.

Kavakcioglu Yardimci, Berna Et Al. "Apatinib sensitizes human breast cancer cells against navitoclax and venetoclax despite up-regulated bcl-2 and mcl-1 gene expressions," Turk Onkoloji Dergisi , vol.36, no.1, 8-16, 2021

Kavakcioglu Yardimci, Berna K. Et Al. "Apatinib sensitizes human breast cancer cells against navitoclax and venetoclax despite up-regulated bcl-2 and mcl-1 gene expressions." Turk Onkoloji Dergisi , vol.36, no.1, pp.8-16, 2021

Kavakcioglu Yardimci, B. Et Al. (2021) . "Apatinib sensitizes human breast cancer cells against navitoclax and venetoclax despite up-regulated bcl-2 and mcl-1 gene expressions." Turk Onkoloji Dergisi , vol.36, no.1, pp.8-16.

@article{article, author={Berna Kavakcioglu Yardimci Et Al. }, title={Apatinib sensitizes human breast cancer cells against navitoclax and venetoclax despite up-regulated bcl-2 and mcl-1 gene expressions}, journal={Turk Onkoloji Dergisi}, year=2021, pages={8-16} }